Sang-Cheol Bae1, Young Ho Lee1,2. 1. a Department of Rheumatology , Hanyang University Hospital for Rheumatic Diseases , Seoul , Korea. 2. b Division of Rheumatology, Department of Internal Medicine , Korea University College of Medicine , Seoul , Korea.
Abstract
OBJECTIVE: We evaluated the relationship between calprotectin levels and rheumatoid arthritis (RA), and the correlation between plasma/serum calprotectin and RA activity. METHODS: We searched PUBMED, EMBASE, and Cochrane databases and performed meta-analyses comparing plasma/serum or synovial fluid calprotectin levels in RA patients and controls, and correlation coefficients between calprotectin levels and disease activity for 28 joints (DAS28) as well as C-reactive protein (CRP) in RA patients. RESULTS: Sixteen studies including 849 RA patients and 266 controls were available for meta-analysis. Meta-analysis showed that calprotectin levels were significantly higher in the RA group than in the control group (SMD = 2.337, 95% CI = 1.544-3.130, p < 1.0 × 10-8). Stratification by rheumatoid factor (RF) status revealed significantly elevated calprotectin levels in the RF-positive RA group compared to that of the RF-negative RA group (SMD = 0.574, 95% CI = 0.345-0.804, p = 9.2 × 10-7). Meta-analysis of correlation coefficients identified a significant positive correlation between calprotectin levels and CRP or DAS28 (correlation coefficient for CRP = 0.566, 95% CI = 0.512-0.615, p < 1.0 × 10-8; correlation coefficient for DAS28 = 0.438, 95% CI = 0.269-0.518, p = 2.5 × 10-6). Calprotectin levels in synovial fluid were significantly higher in the RA group than in the control group (SMD = 2.891, 95% CI = 1.067-4.715, p = 0.002). CONCLUSIONS: Our meta-analysis demonstrates that circulating and synovial fluid calprotectin levels are high in patients with RA, and that circulating calprotectin levels positively correlate with RA activity.
OBJECTIVE: We evaluated the relationship between calprotectin levels and rheumatoid arthritis (RA), and the correlation between plasma/serum calprotectin and RA activity. METHODS: We searched PUBMED, EMBASE, and Cochrane databases and performed meta-analyses comparing plasma/serum or synovial fluid calprotectin levels in RA patients and controls, and correlation coefficients between calprotectin levels and disease activity for 28 joints (DAS28) as well as C-reactive protein (CRP) in RA patients. RESULTS: Sixteen studies including 849 RA patients and 266 controls were available for meta-analysis. Meta-analysis showed that calprotectin levels were significantly higher in the RA group than in the control group (SMD = 2.337, 95% CI = 1.544-3.130, p < 1.0 × 10-8). Stratification by rheumatoid factor (RF) status revealed significantly elevated calprotectin levels in the RF-positive RA group compared to that of the RF-negative RA group (SMD = 0.574, 95% CI = 0.345-0.804, p = 9.2 × 10-7). Meta-analysis of correlation coefficients identified a significant positive correlation between calprotectin levels and CRP or DAS28 (correlation coefficient for CRP = 0.566, 95% CI = 0.512-0.615, p < 1.0 × 10-8; correlation coefficient for DAS28 = 0.438, 95% CI = 0.269-0.518, p = 2.5 × 10-6). Calprotectin levels in synovial fluid were significantly higher in the RA group than in the control group (SMD = 2.891, 95% CI = 1.067-4.715, p = 0.002). CONCLUSIONS: Our meta-analysis demonstrates that circulating and synovial fluid calprotectin levels are high in patients with RA, and that circulating calprotectin levels positively correlate with RA activity.
Authors: Santiago Muñoz-Fernández; Teresa Otón-Sánchez; Loreto Carmona; Jaime Calvo-Alén; Alejandro Escudero; Javier Narváez; Jose Manuel Rodríguez Heredia; Susana Romero Yuste; Paloma Vela; Sara Luján Valdés; Ana Royo García; José Luis Baquero Journal: Rheumatol Int Date: 2018-09-24 Impact factor: 2.631
Authors: Lieke Tweehuysen; Nathan den Broeder; Noortje van Herwaarden; Leo A B Joosten; Peter L van Lent; Thomas Vogl; Frank H J van den Hoogen; Rogier M Thurlings; Alfons A den Broeder Journal: RMD Open Date: 2018-04-09
Authors: Emma C de Moel; Jürgen Rech; Michael Mahler; Johannes Roth; Thomas Vogl; Anne Schouffoer; Robbert J Goekoop; Tom W J Huizinga; Cornelia F Allaart; René E M Toes; Georg Schett; Diane van der Woude Journal: Arthritis Res Ther Date: 2019-12-05 Impact factor: 5.156
Authors: Isaac T Cheng; Huan Meng; Martin Li; Edmund K Li; Priscilla C Wong; Jack Lee; Bryan P Yan; Alex P W Lee; Ho So; Lai-Shan Tam Journal: Front Med (Lausanne) Date: 2022-07-08
Authors: Matthias Jarlborg; Delphine S Courvoisier; Céline Lamacchia; Laura Martinez Prat; Michael Mahler; Chelsea Bentow; Axel Finckh; Cem Gabay; Michael J Nissen Journal: Arthritis Res Ther Date: 2020-05-06 Impact factor: 5.156